The $736 Million GRAT Tax Dispute: What the Elcan Case Teaches About Tax Strategy Execution
A Nashville couple, Trisha and Chuck Elcan, are now fighting the IRS over a gift tax bill of roughly $736 million — $614 million in tax plus $122 million in penalties — tied to a GRAT strategy that estate planners have used for decades. The case, Elcan v. Commissioner (Tax Court Docket No. 3405-25), is still pending; the Tax Court hasn't ruled on the taxpayers' motion for summary judgment, and the Elcans dispute the IRS's position. But the number alone is worth sitting with, because the strategy at the center of it isn't exotic or aggressive on its face. It's one of the most common tools in high-net-worth estate planning. What's in dispute is how it was executed.
That gap — between a legitimate strategy and a correctly executed one — is where most of the real risk in sophisticated tax planning actually lives, and it's a lesson that applies well below nine figures.
What Happened: Inside the $736 Million GRAT Tax Dispute
In 2018, the Elcans set up three grantor retained annuity trusts, funded with interests in HCA Healthcare stock valued at roughly $1.5 billion. The first two GRATs had already passed around $200 million to trusts for their daughters by the time the IRS challenged the structure.
The dispute centers on how the trusts operated internally. Trisha Elcan used interest-bearing promissory notes to buy assets out of the GRATs — a routine estate-planning move called a substitution or "swap" power, which lets a grantor exchange assets of equal value with a trust they created. Later, the trustee satisfied the GRATs' required annuity payments back to her, in part, by forgiving portions of those notes rather than paying in cash.
The IRS says that arrangement violates Section 2702 of the Internal Revenue Code and the Treasury regulations governing GRATs, which prohibit satisfying a GRAT's annuity payments with a note. The agency's broader argument is that the substitution power was used as an indirect step transaction — a way to accomplish, through a swap and a later forgiveness, the same thing the regulations directly forbid. If the IRS prevails, the consequence is severe: not just a recalculation of the trust's growth, but treatment of the entire $687.5 million initially transferred into the GRATs as a taxable gift, on the theory that a GRAT failing to meet the regulatory requirements from inception was never a qualified interest at all.
Why "It's a Legitimate Strategy" Misses the Real Risk
Every summary of this case, including the one that likely reached you, describes the GRAT itself as legal. That's true, and it's also the part that makes this story misleading if you stop there. The public read on cases like this is usually binary: either a strategy works or it's a scam. Sophisticated tax planning doesn't fail that way. It fails in the mechanics — the sequencing of a transaction, the form a payment takes, whether a power was exercised the way the regulations assume it will be.
A GRAT only delivers its tax benefit if it satisfies a specific set of regulatory conditions continuously, not just at the moment it's drafted. Change how the annuity gets paid, and you can unintentionally convert a instrument that was supposed to shield only the trust's growth from gift tax into one where the IRS argues the entire contribution was a gift. The name of the strategy on your estate plan doesn't carry that protection. The administration of it does.
How a GRAT Actually Works — and Where the Elcan Structure Diverged
A grantor retained annuity trust lets someone contribute assets to a trust while retaining the right to fixed annuity payments for a set term. The IRS assumes the trust's assets will grow at a specific published rate (the Section 7520 rate); if the actual return exceeds that rate, the excess passes to the remainder beneficiaries — typically children — largely free of additional gift tax. It's a bet that your assets will outperform a modest, IRS-assumed hurdle rate, and it's been standard practice in estate planning since the 1990s.
Many GRATs also include a substitution power, allowing the grantor to swap assets of equivalent value in and out of the trust. Because the trust is a "grantor trust" for income tax purposes, this kind of swap generally doesn't trigger a taxable sale. It's a legitimate and widely used tool — often used to pull appreciated stock back to the grantor's personal balance sheet while replacing it with cash or other assets of equal value inside the trust.
What the IRS objects to in the Elcan case is the combination: a promissory note used in the substitution, later satisfied by forgiveness that also functioned as the annuity payment the trust owed back to Trisha Elcan. Treasury regulations are specific that a GRAT's mandatory annuity payments have to be made in a way that meets defined requirements — a note doesn't qualify. The IRS's theory is that layering a substitution transaction on top of a note, then using forgiveness to functionally deliver the annuity payment, reaches the same prohibited outcome by a different route. Whether a court agrees is exactly what's being litigated. What's not in dispute is that the difference between "compliant" and "non-compliant" here sits entirely in transaction mechanics that most people would consider a technical detail — not the headline strategy.
What to Check in Your Own GRAT or Trust Strategy
You don't need a $1.5 billion HCA Healthcare position for this case to be relevant. Anyone using a GRAT, an installment sale to a grantor trust, or any strategy built around a substitution power should be able to answer these plainly:
How are the trust's required payments actually being satisfied — cash, in-kind assets, or something else? If a note, a forgiveness, or any non-cash instrument shows up in the payment mechanics, that's exactly the detail worth a second look before it becomes a pattern across multiple years.
Is every substitution transaction documented as its own arm's-length exchange, with its own valuation? A swap of equivalent value needs a real valuation behind it at the time it happens, not a number assigned after the fact to make the math work.
Does the sequence of events look like two separate, independent transactions, or one transaction dressed as two? The step transaction doctrine exists precisely because the IRS is allowed to look at substance over form when transactions are connected in timing and purpose.
Who is administering the trust, and are they applying the same discipline every year? A trustee who treats annual compliance as a formality rather than a live requirement is the most common way a technically sound structure drifts into a non-compliant one over time.
When was the strategy last reviewed against current guidance, not just the guidance in effect when it was drafted? A structure built in 2018 that hasn't been revisited since is running on assumptions that may no longer match how aggressively this area is being examined.
Where This Gets Complicated Enough to Need Help
None of this means GRATs, substitution powers, or promissory notes inside trusts are inherently risky tools — they aren't, and they remain standard components of legitimate estate planning for a reason. The risk shows up specifically where a technically correct instrument gets administered in a way nobody stress-tested against the regulations governing it. That's rarely a legal question alone; it's an execution and documentation question, which is exactly where a business-minded read of the numbers matters as much as the legal drafting.
If you have a trust structure, a substitution power, or any wealth-transfer vehicle that hasn't had its actual year-to-year administration reviewed — not just its original drafting — that's worth a direct look before a routine transaction becomes the fact pattern someone else has to explain to a court.
Comments